Jump to:
loading...| Preferred Name |
Hemolytic Anemia |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C34376 |
| ALT_DEFINITION |
due to premature destruction of erythrocytes in the spleen or peripheral vessels; commonly associated with glucose-6-phosphate dehydrogenase deficiencies, splenomegaly, and malarial or other infections. Anemia due to decreased life span of erythrocytes. |
| code |
C34376 |
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C90259 |
| Contributing_Source |
NICHD FDA |
| DEFINITION |
Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies. |
| FDA_Table |
Patient Code (Appendix B) |
| FULL_SYN |
Anemia, Hemolytic |
| Has_CDRH_Parent | |
| Has_NICHD_Parent | |
| label |
Hemolytic Anemia |
| Legacy_Concept_Name |
Hemolytic_Anemia |
| NICHD_Hierarchy_Term |
Hemolytic Anemia |
| Preferred_Name |
Hemolytic Anemia |
| prefixIRI |
C34376 |
| prefLabel |
Hemolytic Anemia |
| Semantic_Type |
Disease or Syndrome |
| UMLS_CUI |
C0002878 |
| subClassOf |
Create New Mapping